Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites

摘要

The present invention relates to the use of mannoheptulose for the manufacture of a composition for maintaining and/or attenuating a decline in the quality of life of a mammal, wherein said composition provides a dosage of mannoheptulose to said mammal on a daily basis from about 0.001 gram per kilogram of body weight to said mammal to 1 gram per kilogram of body weight of said mammal..